Peyronnet B, Mironska E, Chapple C, et al. A comprehensive review of overactive bladder pathophysiology: on the way to tailored treatment. Eur Urol. 2019;75(6):988–1000.

Article  Google Scholar 

Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50(6):1306–15.

Article  Google Scholar 

Lin X-D, Lin N, Ke Z-B, Xu N, Jiang P, Li H. Effects of overactive bladder syndrome on female sexual function. Medicine. 2021;100(20);e25761.

Article  CAS  Google Scholar 

Raju R, Linder BJ. Evaluation and treatment of overactive bladder in women. Mayo Clin Proc. 2020;95(2):370–7.

Article  Google Scholar 

Herbison P, Hay-Smith J, Ellis G, Moore K. Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review. BMJ. 2003;326(7394):841.

Article  CAS  Google Scholar 

Chapple CR, Khullar V, Gabriel Z, Muston D, Bitoun CE, Weinstein D. The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur Urol. 2008;54(3):543–62.

Article  CAS  Google Scholar 

Solifenacin and darifenacin for overactive bladder. Obstet Gynecol. 2005;106(2):401–2. https://doi.org/10.1097/01.AOG.0000173816.33966.ed.

Thomas TN, Walters MD. AUGS consensus statement: association of anticholinergic medication use and cognition in women with overactive bladder. Female Pelvic Med Reconstr Surg. 2017;23(3):177–8.

Article  Google Scholar 

Wang J, Zhou Z, Cui Y, et al. Meta-analysis of the efficacy and safety of mirabegron and solifenacin monotherapy for overactive bladder. Neurourol Urodyn. 2019;38(1):22–30.

Article  Google Scholar 

Acar Ö, Erton ML, Tarcan T. Insights into the management of overactive bladder: what difference can mirabegron make? J Urol Surg. 2019;6(2):85.

Article  Google Scholar 

Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100–7.

Article  Google Scholar 

Lee M, Chung Y-J, Kim H-K, et al. Estimated prevalence and incidence of uterine leiomyoma, and its treatment trend in south Korean women for 12 years: a national population-based study. J Womens Health. 2021;30(7):1038–46.

Article  Google Scholar 

Vilos GA, Allaire C, Laberge P-Y, et al. The management of uterine leiomyomas. J Obstet Gynaecol Can. 2015;37(2):157–78.

Article  Google Scholar 

Madueke-Laveaux OS, Elsharoud A, Al-Hendy A. What we know about the long-term risks of hysterectomy for benign indication—a systematic review. J Clin Med. 2021;10(22):5335.

Article  CAS  Google Scholar 

Li P-C, Huang H-K, Ding D-C. Hysterectomy associated with de novo lower urinary tract symptoms in a Taiwanese population: a nationwide, population-based study. Int Urogynecol J. 2019;30(10):1711–7.

Article  Google Scholar 

Selcuk S, Cam C, Asoglu MR, et al. Effect of simple and radical hysterectomy on quality of life–analysis of all aspects of pelvic floor dysfunction. Eur J Obstet Gynecol Reprod Biol. 2016;198:84–8.

Article  Google Scholar 

Berujon E, Thubert T, Fauvet R, Villot A, Pizzoferrato A-C. Impact of uterine fibroid surgery on lower urinary tract symptoms. J Gynecol Obstet Human Reprod. 2022;51(5):102355.

Article  Google Scholar 

Tikkinen KA, Auvinen A, Tiitinen A, Valpas A, Johnson TM II, Tammela TL. Reproductive factors associated with nocturia and urinary urgency in women: a population-based study in Finland. Am J Obstet Gynecol. 2008;199(2):153.e1–12.

Article  Google Scholar 

Altman D, López A, Falconer C, Zetterström J. The impact of hysterectomy on lower urinary tract symptoms. Int Urogynecol J. 2003;14(6):418–23.

Article  Google Scholar 

Kim L, Kim J-A, Kim S. A guide for the utilization of health insurance review and assessment service national patient samples. Epidemiol Health. 2014;36:e2014008.

Article  Google Scholar 

Ulin M, Ali M, Chaudhry ZT, Al-Hendy A, Yang Q. Uterine fibroids in menopause and perimenopause. Menopause. 2020;27(2):238.

Article  Google Scholar 

Hwang S, Kang SW, Choi KJ, et al. Early menopause is associated with increased risk of retinal vascular occlusions: a nationwide cohort study. Sci Rep. 2022;12(1):1–10.

Article  CAS  Google Scholar 

Li J-R, Wang S-S, Lin C-H, De Groat WC, Cheng C-L. Positive association of male overactive bladder symptoms and androgen deprivation: a nationwide population-based cohort study. Anticancer Res. 2019;39(1):305–11.

Article  Google Scholar 

Cheng C-L, Li J-R, Lin C-H, de Groat WC. Positive association of female overactive bladder symptoms and estrogen deprivation: a nationwide population-based cohort study in Taiwan. Medicine. 2016;95(28):e4107.

Article  CAS  Google Scholar 

Haab F, Castro-Diaz D. Persistence with antimuscarinic therapy in patients with overactive bladder. Int J Clin Pract. 2005;59(8):931–7.

Article  CAS  Google Scholar 

Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–82.

Article  Google Scholar 

Iosif CS, Batra S, Ek A, Åstedt B. Estrogen receptors in the human female lower urinary tract. Am J Obstet Gynecol. 1981;141(7):817–20.

Article  CAS  Google Scholar 

Versi E, Harvey M-A, Cardozo L, Brincat M, Studd J. Urogenital prolapse and atrophy at menopause: a prevalence study. Int Urogynecol J. 2001;12(2):107–10.

Article  CAS  Google Scholar 

DeLancey JO. Anatomic aspects of vaginal eversion after hysterectomy. Am J Obstet Gynecol. 1992;166(6):1717–28.

Article  CAS  Google Scholar 

Maas CP, Kenter GG, Trimbos JB, Deruiter MC. Anatomical basis for nerve-sparing radical hysterectomy: immunohistochemical study of the pelvic autonomic nerves. Acta Obstet Gynecol Scand. 2005;84(9):868–74.

Article  Google Scholar